新疆天山畜牧生物工程股份有限公司 详式权益变动报告书 之 财务顾问核查意见 北京博星证券投资顾问有限公司 财务顾问核查意见 北京博星证券投资顾问有限公司 关于 2025 年 12 月 | | | 北京博星证券投资顾问有限公司 财务顾问核查意见 第一节 释义 在本核查意见中，除非文意另有所指，下列词语具有如下含义： | 天山/上市公司/公司 *ST | 指 | 新疆天山畜牧生物工程股份有限公司 | | --- | --- | --- | | 信息披露义务人/厦门舍 | 指 | 厦门舍德供应链管理有限公司 | | 德 | | | | 厦门谷德 | 指 | 厦门谷德供应链管理有限公司 | | 谷德工贸 | 指 | 厦门谷德工贸有限公司 | | 湖州皓辉 | 指 | 湖州皓辉企业管理咨询有限公司 | | 湖州中植 | 指 | 湖州中植融云投资有限公司 | | 本次回购注销股份 | 指 | 上市公司对已划转至回购专用证券账户 股涉案股 73,198,402 份（占注销前公司总股本的 23.39%）予以注销，并依法办理 | | | | 注册资本变更、工商变更登记及备案等手续 | | 本次权益变动 | 指 | 因上市公司实 ...

| 变更内容 | 变更前 | | 变更后 | | | --- | --- | --- | --- | --- | | 办公地址 | 新疆昌吉市宁边西路 | 262 号 | 新疆昌吉市北京北路 | 569 号 | | 邮政编码 | 831100 | | 831100 | | 除上述变更内容外，公司官网网址、注册地址、经营地址等其他联系方式保 持不变。 以上变更事项自本公告发布之日起正式启用，欢迎广大投资者通过上述渠道 与公司保持沟通联系。若由此给您带来不便，敬请谅解！ 特此公告。 新疆天山畜牧生物工程股份有限公司董事会 二〇二五年十二月三日 证券代码：300313 证券简称：*ST天山 公告编号：2025-068 新疆天山畜牧生物工程股份有限公司 关于办公地址变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 新疆天山畜牧生物工程股份有限公司（以下简称"公司"）办公地址发生变 更。为保证投资者交流渠道通畅，现将具体变更内容公告如下： ...

证券代码：300313 证券简称：*ST天山 公告编号：2025-067 新疆天山畜牧生物工程股份有限公司 关于公司回购专用证券账户股份注销完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、新疆天山畜牧生物工程股份有限公司（以下简称"公司"）本次注销回 购专用证券账户股份数量为 73,198,402 股，占注销前公司总股本的 23.39%。本 次注销完成后，公司总股本由 312,977,396 股变更为 239,778,994 股，相应的注 册资本由 312,977,396 元变更为 239,778,994 元。 2、根据中国证券登记结算有限责任公司深圳分公司出具的《注销证券结果 报表》，公司此次回购专用证券账户股份的注销事宜已于 2025 年 12 月 2 日办理 完成。 一、注销股份的基本情况 2018 年 12 月，公司发现陈德宏等人涉嫌违法违规行为，同日公司合同诈骗 事项被刑事立案。根据昌吉州中院 2021 年 9 月作出的【（2020）新 23 刑初 7 号】《刑事判决书》及新疆维吾尔自治区高级人民法院 2023 年 4 月 ...

Group 1 - The core point of the article is that *ST Tianshan (300313.SZ) reported significant increases in both the number of livestock sold and sales revenue for November 2025, indicating strong performance in the livestock sector [1] Group 2 - In November 2025, the company sold 2,892 head of livestock, representing a month-on-month increase of 111.56% [1] - The sales revenue for the same month reached 35.3362 million yuan, with a month-on-month increase of 164.72% [1] - Year-on-year comparisons show a substantial increase in livestock sales by 531.44% and sales revenue by 725.16% [1]

证券代码：300313 证券简称：*ST天山 公告编号：2025-065 新疆天山畜牧生物工程股份有限公司 关于收到广东省高级人民法院执行裁定书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 新疆天山畜牧生物工程股份有限公司（以下简称"公司"或"天山生物"） 近日收到广东省高级人民法院（以下简称"广东高院"）（2025）粤执复 232 号《执行裁定书》。现将相关情况公告如下： 一、案件情况说明 2023 年 11 月，公司收到广东省广州市中级人民法院（以下简称"广州中院"） 发来的（2023）粤 01 执恢 437 号《协助查询函》，其中载明广州中院受理的申 请执行人华融渝富股权投资基金管理有限公司与被执行人陈德宏、鲁虹、东莞市 大象实业投资有限公司、东莞市信佳贸易有限公司、东莞市嘉盈实业投资有限公 司、东莞市汇春园林绿化工程有限公司公证债权文书一案，因被执行人未履行上 述生效法律文书所确定的义务，申请执行人向法院申请强制执行。因被执行人未 按执行通知履行上述法律文书确定的义务，广州中院拟对被执行人陈德宏持有的 天山生物 2000 万股股票及孳息作评估 ...

一、2025 年 11 月销售情况简报 新疆天山畜牧生物工程股份有限公司（以下简称"公司"）2025 年 11 月销 售活畜 2,892 头，销售收入 3,533.62 万元，环比变动分别为 111.56%、164.72%； 同比变动分别为 531.44%、725.16%。 证券代码：300313 证券简称：*ST天山 公告编号：2025-066 新疆天山畜牧生物工程股份有限公司 2025 年 11 月活畜销售情况简报 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 （二）上述披露仅包含公司活畜销售情况，不含其他业务。 （三）《证券时报》《上海证券报》以及巨潮资讯网（www.cninfo.com.cn） 为公司指定的信息披露媒体，公司所有信息均以公司在上述媒体刊登的公告为准。 敬请广大投资者审慎决策，注意投资风险。 特此公告。 新疆天山畜牧生物工程股份有限公司董事会 二〇二五年十二月一日 二、原因说明 根据公司战略布局、整体经营计划并结合市场需求等综合考量，公司适时调 整牛只养殖周期与出栏计划。本月活畜销售数量与收入同比增长，主要得益于公 司战略布局落地后的产 ...

Core Viewpoint - A block trade of *ST Tianshan occurred on November 26, with a transaction volume of 250,000 shares and a transaction amount of 2.7875 million yuan, at a price of 11.15 yuan, representing a premium of 16.39% over the closing price of the day [2] Group 1: Trading Details - The block trade involved a buy-side brokerage from CITIC Securities Co., Ltd. Beijing Dongcheng Branch and a sell-side brokerage from Ping An Securities Co., Ltd. Beijing Financial Street Securities Branch [2] - The closing price of *ST Tianshan on the same day was 9.58 yuan, reflecting an increase of 3.12% [2] - The daily turnover rate was 3.83%, with a total transaction amount of 72.4854 million yuan and a net inflow of main funds amounting to 306,500 yuan [2] Group 2: Recent Performance - Over the past five days, *ST Tianshan has seen a cumulative decline of 3.43%, with total fund outflow amounting to 8.1445 million yuan [2] - The company, Xinjiang Tianshan Animal Husbandry Biotechnology Co., Ltd., was established on June 18, 2003, with a registered capital of 3,129.77396 million yuan [2]

Group 1 - The stock of *ST Tianshan closed at 9.58 yuan, with an increase of 3.12% on November 26 [1] - A block trade occurred with a total volume of 250,000 shares and a transaction amount of 2.7875 million yuan, with a premium rate of 16.39% [1] - The buyer was CITIC Construction Investment Securities Co., Ltd., and the seller was Ping An Securities Co., Ltd. [1] Group 2 - In the last three months, there has been one block trade for this stock, totaling 2.7875 million yuan [1] - Over the past five trading days, the stock has decreased by 3.43%, with a total net outflow of 13.8146 million yuan from main funds [1]

Group 1 - The core transaction involved *ST Tianshan, with a total of 250,000 shares traded on November 26, resulting in a transaction amount of 2.7875 million yuan, which accounted for 3.7% of the total trading volume for that day [1][2] - The transaction price was 11.15 yuan per share, representing a premium of 16.39% compared to the market closing price of 9.58 yuan [1][2] - The buyer was CITIC Securities Co., Ltd., while the seller was Ping An Securities Co., Ltd. [2]

Core Viewpoint - Yitong Century Technology Co., Ltd. has received a criminal judgment from the Guangzhou Intermediate People's Court regarding a long-standing merger and acquisition financial fraud case, marking a significant step in judicial accountability against financial fraud in China [1][2]. Group 1: Case Background - In 2016, Yitong Century initiated a major asset restructuring, acquiring 100% of Shenzhen Beitai Health Measurement Analysis Technology Co., Ltd. for a total consideration of 1 billion yuan, with a commitment from the sellers to achieve a cumulative net profit of no less than 311 million yuan from 2016 to 2019 [2]. - The fraud involved the fabrication of orders by Beitai Health, leading to financial misstatements in Yitong Century's 2017 annual report, resulting in administrative penalties from the China Securities Regulatory Commission [2]. Group 2: Judicial Outcomes - The court sentenced Xu Mouqun to five years in prison and imposed a fine of 500,000 yuan for his role in the fraud, which included providing funds and assisting in financial deception, causing significant economic losses to Yitong Century [1][3]. - The court also ordered the recovery of 40 million yuan in illegal gains from Xu, with provisions for further compensation if the recovery was insufficient [1]. Group 3: Regulatory Environment - The case reflects a broader trend in China's regulatory environment, emphasizing a dual approach of targeting both the principal offenders and accomplices in financial fraud cases, thereby enhancing market integrity and protecting investors' rights [1][4]. - The China Securities Regulatory Commission has reinforced its stance on punishing accomplices in financial fraud, indicating a shift towards a more comprehensive accountability framework [4][6]. Group 4: Industry Implications - The increasing severity of penalties for financial fraud, including criminal charges against accomplices, aims to deter potential fraudsters and purify the market environment [8][9]. - The establishment of a multi-dimensional accountability system is intended to create clear behavioral boundaries for market participants, thereby safeguarding investors' legitimate rights and interests [8][9].